According to Chemical and Engineering News’s (C&EN) latest annual capital and R&D spending survey, 18 US and European chemical companies stated that 2015 R&D levels were virtually the same as 2014. Total R&D spending made up 3.4% of companies’ revenues, while R&D spending for all surveyed firms increased 0.3% from $9.88 billion to $9.91 billion. […]
Writing in the New England Journal of Medicine, the National Cancer Institute’s Douglas R. Lowy, MD, and the NIH’s Francis S. Collins, MD, PhD, summarized the agenda for the US government’s latest cancer research initiative (see IBO 2/15/16). Among the reasons that a new effort is needed at this time is technological progress and scientific […]
A report examining 56 countries’ contributions to the global biopharmaceutical sector based on their respective national policies was released this month. It found that the US, Switzerland and Taiwan are the top three countries whose innovations in life sciences are helping grow the biopharma industry, while India, South Africa and Thailand have policies that are […]
In a Pew Charitable Trusts’ analysis of the National Residue Program (NRP), implemented by the Food Safety and Inspection Service (FSIS) of the USDA, issues were found regarding the type of drug and chemical compounds that are selected for public health assessment, as well as the documenting and reporting of testing results. This is considered […]
In 2015, there were 61 IPOs across western stock exchanges, down from 87 in 2014, with companies raising $4.68 billion, compared to $6.3 billion in 2014. Total US and EU venture capital (VC) funding grew 34.4% and 46.4% to $7.04 billion and $2.02 billion, respectively, although the number of rounds for each region declined. To […]
Although energy firms are cutting costs and reducing employees due to bottoming oil prices, North American research organizations and companies are increasing efforts to enhance the productivity of oil production. By creating new labs and hiring more employees, research institutions are taking advantage of the slowdown in the oil industry to come up with new […]
The International Energy Agency (IEA) has stated that oil prices may have “bottomed out” due to a decrease in production outside the Organization of Petroleum Exporting Countries (OPEC). Oil production outside OPEC is forecast to decrease by 750,000 barrels/day for 2016. This number is 150,000 barrels/day more than IEA estimates from January. Since hitting the […]
According to Reuters’ “Top 25 Global Innovators—Government” list, the Alternative Energies and Atomic Energy Commission (CEA) (France), the Fraunhofer Society (Germany), and the Science and Technology Agency (Japan) are the top three most pioneering government-funded institutions that are advancing science and technology. The US has six institutions on the list, France and Japan both have […]
A recent study has calculated the average cost for drug development (including marketing approval) at $2.558 billion. According to Tufts Center for the Study of Drug Development, this figure was reached through estimating average out-of-pocket costs to be $1.395 billion and time costs to be $1.163 billion. Once the drug is approved, R&D costs for […]
At January’s end, President Obama established the Cancer Moonshot Task Force, which aims to enable developments in cancer research. The National Cancer Moonshot is a $1 billion initiative to aid scientists and researchers in accelerating research and treatments for cancer. For 2016, $195 million in new cancer-related activities at the NIH has been invested, and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
